Literature DB >> 16457972

Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin.

Yasuyuki Sadzuka1, Ikumi Sugiyama, Tomoko Tsuruda, Takashi Sonobe.   

Abstract

Liposomes are recognized as one of the useful drug carriers, but have many problems to overcome before their clinical application. Liposomes, bonding peculiarly with serum protein (opsonization), are taken up by reticuloendothelial system (RES) cells in the liver and spleen. It is known that polyethyleneglycol (PEG) modification of the liposome surface induces the formation of a fixed aqueous layer around the liposomes due to the interaction between the PEG-polymer and water molecule, and thus prevents the attraction of opsonins. Namely, PEG-modified liposomes are able to escape trapping by the RES cells, and have a prolonged circulation time. In this study, the effects of different anchors with the same PEG molecular weight on the cell uptake and cytotoxicity of mixed PEG-modified liposomal doxorubicin (DOX) were examined. The fixed aqueous layer thickness (FALT) of liposomes covered with mixtures of PEG-molecules which differ in their chain length were increased, compared to that of the single PEG2000-modified liposome. Mixed PEG-modification of liposomes with different anchors (PEG2000-(1-monomethoxypolyethyleneglycol-2,3-distearoylglycerol (DSG): cholesterol (CHO)=1:1)-modified liposome) led to an increase in the FALT, compared to that of each single PEG-modification. The uptake of DOX into Ehrlich ascites carcinoma cells by the liposomes covered with PEG-CHO was higher than the other liposomes. Thus, liposomes covered with PEG-DSG and PEG-CHO have an enhanced cytotoxicity. In conclusion, it was confirmed that mix-modified liposomes using PEG-lipid with different anchors were superior.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16457972     DOI: 10.1016/j.ijpharm.2005.12.043

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

Review 1.  Biomaterials for the central nervous system.

Authors:  Yinghui Zhong; Ravi V Bellamkonda
Journal:  J R Soc Interface       Date:  2008-09-06       Impact factor: 4.118

2.  Unique uptake of acid-prepared mesoporous spheres by lung epithelial and mesothelioma cells.

Authors:  Steven R Blumen; Kai Cheng; Maria E Ramos-Nino; Douglas J Taatjes; Daniel J Weiss; Christopher C Landry; Brooke T Mossman
Journal:  Am J Respir Cell Mol Biol       Date:  2006-10-12       Impact factor: 6.914

3.  Development of AE147 Peptide-Conjugated Nanocarriers for Targeting uPAR-Overexpressing Cancer Cells.

Authors:  June Yong Park; Yuseon Shin; Woong Roeck Won; Chaemin Lim; Jae Chang Kim; Kioh Kang; Patihul Husni; Eun Seong Lee; Yu Seok Youn; Kyung Taek Oh
Journal:  Int J Nanomedicine       Date:  2021-08-12

4.  Influence of PEG coating on the biodistribution and tumor accumulation of pH-sensitive liposomes.

Authors:  Shirleide Santos Nunes; Renata Salgado Fernandes; Carolina Henriques Cavalcante; Isabela da Costa César; Elaine Amaral Leite; Sávia Caldeira Araújo Lopes; Alice Ferretti; Domenico Rubello; Danyelle M Townsend; Mônica Cristina de Oliveira; Valbert Nascimento Cardoso; André Luís Branco de Barros
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

5.  The efficacy of mitochondrial targeting antiresistant epirubicin liposomes in treating resistant leukemia in animals.

Authors:  Ying Men; Xiao-Xing Wang; Ruo-Jing Li; Yan Zhang; Wei Tian; Hong-Juan Yao; Rui-Jun Ju; Xue Ying; Jia Zhou; Nan Li; Liang Zhang; Yang Yu; Wan-Liang Lu
Journal:  Int J Nanomedicine       Date:  2011-12-02

6.  A Comparison of Clinical Prognostic Indices in Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with a Pegylated Liposomal Doxorubicin Combination Regimen in China.

Authors:  Hongye Gao; Yanfeng Xu; Yanfei Liu; Lan Mi; Xiaopei Wang; Weiping Liu; Jun Zhu; Yuqin Song
Journal:  Cancer Manag Res       Date:  2022-09-14       Impact factor: 3.602

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.